Sotera Health Company $SHC Shares Acquired by Irenic Capital Management LP

Key Points

• Irenic Capital Management LP increased its stake in Sotera Health Company by 7.2%, now owning approximately 3.1 million shares, which makes up about 5.5% of its investment portfolio.
• Analysts have recently upgraded Sotera Health's rating from "buy" to "strong-buy", with the target price raised from $14.00 to $17.00, reflecting positive sentiment towards the stock's performance.
• Insider Michael P. Rutz sold over 126,000 shares of Sotera Health, a transaction that decreased his ownership by nearly 22%, indicating significant insider trading activity.

Irenic Capital Management LP boosted its stake in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 7.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 3,117,226 shares of the company's stock after buying an additional 208,063 shares during the period. Sotera Health makes up approximately 5.5% of Irenic Capital Management LP's holdings, making the stock its 5th largest holding. Irenic Capital Management LP owned approximately 1.10% of Sotera Health worth $36,347,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Quarry LP purchased a new stake in Sotera Health during the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd raised its holdings in Sotera Health by 3,690.1% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock valued at $31,000 after buying an additional 2,620 shares during the period. Summit Securities Group LLC purchased a new stake in Sotera Health during the 1st quarter valued at $67,000. Tower Research Capital LLC TRC raised its holdings in Sotera Health by 37.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after buying an additional 1,640 shares during the period. Finally, Farther Finance Advisors LLC raised its holdings in Sotera Health by 4,881.9% during the 1st quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock valued at $70,000 after buying an additional 6,200 shares during the period. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Price Performance

Shares of NASDAQ:SHC traded down $0.48 during trading on Thursday, reaching $15.50. The stock had a trading volume of 8,519,980 shares, compared to its average volume of 1,297,579. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47. The business has a fifty day moving average price of $13.17 and a 200-day moving average price of $12.32. The stock has a market cap of $4.40 billion, a PE ratio of 193.77 and a beta of 1.84. Sotera Health Company has a 1-year low of $9.53 and a 1-year high of $17.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported $0.20 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. The company had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. Sotera Health's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 16th. Barclays reiterated an "overweight" rating on shares of Sotera Health in a research report on Friday, August 8th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Sotera Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $16.00.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, insider Michael P. Rutz sold 126,611 shares of Sotera Health stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the sale, the insider owned 450,204 shares in the company, valued at $7,374,341.52. The trade was a 21.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 47.55% of the company's stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.